Wells Fargo’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Wells Fargo’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,400	Closed	-$775K	–	7768
2023 Q1	$775K	Sell	6,400 -4,846	-43%	-$557K	﹤0.01%	3559
2022 Q4	$1.29M	Buy	11,246 +4,615	+70%	+$509K	﹤0.01%	3086
2022 Q3	$671K	Hold	6,631	–	–	﹤0.01%	3501
2022 Q2	$672K	Hold	6,631	–	–	﹤0.01%	3550
2022 Q1	$772K	Sell	6,631 -1,000	-13%	-$116K	﹤0.01%	4096
2021 Q4	$875K	Buy	+7,631	New	+$870K	﹤0.01%	4220
2020 Q4	–	Sell	-3,181	Closed	-$356K	–	7254
2020 Q3	$356K	Sell	3,181 -16,227	-84%	-$1.82M	﹤0.01%	4601
2020 Q2	$2.03M	Buy	+19,408	New	+$2.08M	﹤0.01%	3251

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Wells Fargo's BSX.PRA Position: Q2 2023 in Review

Wells Fargo sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 6,400 shares — an estimated $775K sold.

Wells Fargo first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $2.03M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Wells Fargo reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Wells Fargo sold 6,400 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $775K.
Wells Fargo first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
Wells Fargo's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $2.03M in Q2 2020.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.